<img src="https://www.bostonherald.com/wp-content/uploads/2018/11/HeraldDotComBanner.svg" alt="Boston Herald">

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

December 11, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have realized strong financial performance, and over the past six months, the...

1 Healthcare Stock for Long-Term Investors and 2 We Avoid

December 10, 2025

Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗

Topics Stocks

November 20, 2025

Via Stocktwits

Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗

November 20, 2025

Via Stocktwits

3 Overrated Stocks That Concern Us

December 03, 2025

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

A combination of operational improvements and developments at its key rival bolstered the stock recently.

Here's Why Grail Soared, Again, in November ↗

December 02, 2025

The healthcare leader wants to make waves in a potentially highly lucrative market.

This Top Dividend King Just Became an Even Better Buy ↗

November 30, 2025

Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights

November 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium

November 24, 2025

Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Unusual volume stocks are being observed in Monday's session. ↗

November 24, 2025

Via Chartmill

Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks

November 23, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers.

Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights

Topics Artificial Intelligence

November 22, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

November 21, 2025

From Kahn Swick & Foti, LLC

On a big day for tech stocks, some other less well-known companies saw even larger moves.

Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗

November 20, 2025

The company received a buyout offer from Abbot Labs.

Topics Artificial Intelligence Stocks

Why Exact Sciences Rallied Over 50% This Week ↗

November 20, 2025

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)

November 20, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Why Exact Sciences Stock Surged Today ↗

November 20, 2025

A healthcare giant covets the cancer screening leader's technology.

Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗

November 20, 2025

Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.

Via Benzinga

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗

November 20, 2025

Via Benzinga

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗

November 20, 2025

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.

Via Benzinga

EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders

November 20, 2025

From Halper Sadeh LLC

Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.

Abbott To Acquire Exact Sciences For Up To $23B ↗

November 20, 2025

Via Stocktwits

Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗

November 19, 2025

A strategic investor is reportedly in advanced talks to purchase the company.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

2 Surging Stocks with Competitive Advantages and 1 We Question

November 16, 2025

Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests

November 10, 2025

Exact Sciences’ third quarter results received a positive response from the market, reflecting strong revenue growth and robust execution in its core screening business. Management attributed the...

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call

November 10, 2025

These companies are slowly coming into their own.

Topics Earnings

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

November 08, 2025

Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test

November 07, 2025

An impressive beat-and-raise third quarter made the company a standout that day.

Why Exact Sciences Stock Blasted Higher on Tuesday ↗

November 04, 2025